Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The distal human intestine harbors trillions of microbes that allow us to extract calories from otherwise indigestible dietary polysaccharides. The products of polysaccharide fermentation include short-chain fatty acids that are ligands for Gpr41, a G protein-coupled receptor expressed by a subset of enteroendocrine cells in the gut epithelium. To examine the contribution of Gpr41 to energy balance, we compared Gpr41 −/− and Gpr41 +/+ mice that were either conventionally-raised with a complete gut microbiota or were reared germ-free and then cocolonized as young adults with two prominent members of the human distal gut microbial community: the saccharolytic bacterium, Bacteroides thetaiotaomicron and the methanogenic archaeon, Methanobrevibacter smithii . Both conventionally-raised and gnotobiotic Gpr41 −/− mice colonized with the model fermentative community are significantly leaner and weigh less than their WT (+/+) littermates, despite similar levels of chow consumption. These differences are not evident when germ-free WT and germ-free Gpr41 knockout animals are compared. Functional genomic, biochemical, and physiologic studies of germ-free and cocolonized Gpr41 −/− and +/+ littermates disclosed that Gpr41-deficiency is associated with reduced expression of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility, increased intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [57]
In the citing paper
“indigestible carbohydrates in the diet are fermented by the intestinal microbiota to produce short-chain fatty acids, which regulate immune function54, 55, intestinal hormone production, and lipogenesis56.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“In addition, colonization of adult GF mice, fed a standard polysacchariderich chow diet, with two organisms—Bacteroides thetaiotaomicron, a prominent saccharolytic bacterium in the normal distal human gut microbiota and an adept adaptive forager of polysaccharides (6), plus Methanobrevibacter smithii, a dominant metha…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Adult germ-free (GF) mice are leaner than their age- and gender-matched conventionally raised (CONV-R) counterparts who have acquired a microbiota beginning at birth (1).”
BackgroundSelf-citationTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“Locomotor activity and body temperature were assessed for 5 d using a telemetry device (minimitter PDT-4000; Mini Mitter) beginning 7 d after implantation (20).”
MethodSelf-citationBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1817 · Cited by 1,711 · cited 1×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundLe Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Cited by
Items 101–200 of 1,001
Microbiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.001 · Cited by 420
“Furthermore, the HGC microbiome also has a higher capacity to produce SCFAs that not only are important energy sources for the colonocytes but also function as signaling molecules, modulating intestinal inflammation and metabolism (Donohoe et al., 2011; Fernandes et al., 2014; Samuel et al., 2008; Smith et al., 2013b;…”
BackgroundInfluentialRole of the Microbiome in Energy Regulation and Metabolism
Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.008 · Cited by 421
Macfarlane, G. T., & Macfarlane, S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822fecfe · Cited by 406
“Similar to acetate, this SCFA has been shown to exert a concentration-dependent increase in the frequency of spontaneous contractions in longitudinal and circular rat colonic smooth muscle.23 Propionate reduces food intake and increases satiety in animal-feeding studies,30,31 whereas dietary supplementation of a dairy…”
BackgroundDevelopment of the human gastrointestinal microbiota and insights from high-throughput sequencing
Dominguez-Bello, M. G., Blaser, M. J., Ley, R. E., & Knight, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.011 · Cited by 405
Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour
Fetissov, S. O. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.150 · Cited by 403
Precision Nutrition and the Microbiome, Part I: Current State of the Science
Mills, S., Stanton, C., Lane, J., Smith, G., & Ross, R. (2019) · Nutrients · doi:10.3390/nu11040923 · Cited by 399
Enteroendocrine cells: a review of their role in brain–gut communication
Latorre, R., Sternini, C., De Giorgio, R., & Greenwood‐Van Meerveld, B. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12754 · Cited by 392
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“SCFAs protect the intestinal barrier; acetate, propionate, and butyrate stimulate the intestinal NLRP3 inflammasome, increasing IL-18 secretion and enhancing intestinal barrier integrity [132].”
BackgroundThe Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling
Mazzoli, R., & Pessione, E. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01934 · Cited by 383
“Furthermore, gut microbiota indirectly regulates the release of GLP-1, GLP-2 and PYY by modulating the differentiation of stem cells into EECs, and thus modifying the number of GLPs and PYY secreting L-cells (Everard et al., 2011).”
BackgroundInfluentialMicrobial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
Wichmann, A., Allahyar, A., Greiner, T. U., Plovier, H., Lundén, G. Ö., Larsson, T., Drucker, D. J., Delzenne, N. M., Cani, P. D., & Bäckhed, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.012 · Cited by 380
“Measurement of SCFAs and Palmitate SCFAandpalmitate levels in cecal contentwere analyzedwith amodification of the methods described previously (Moreau et al., 2003; Samuel et al., 2008).”
MethodResultGut microbiota, enteroendocrine functions and metabolism
Cani, P. D., Everard, A., & Duparc, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.008 · Cited by 378
“the gut microbiota itself [16,29,30].”
New-found link between microbiota and obesity
Chakraborti, C. K. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.110 · Cited by 377
Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota
Cani, P. D., & Delzenne, N. M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.016 · Cited by 377
“smithii) did not gain fat mass at the same extent as wild-type littermates did [17 ].”
BackgroundA key genetic factor for fucosyllactose utilization affects infant gut microbiota development
Matsuki, T., Yahagi, K., Mori, H., Matsumoto, H., Hara, T., Tajima, S., Ogawa, E., Kodama, H., Yamamoto, K., Yamada, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms11939 · Cited by 373
A novel SCFA receptor, the microbiota, and blood pressure regulation
Pluznick, J. (2014) · Gut Microbes · doi:10.4161/gmic.27492 · Cited by 374
“In recent years, it has become widely appreciated that SCFAs are naturally present in the plasma as a consequence of gut microbe metabolism, and that they play important roles in many aspects of host physiology.(9,10,22,28,29,34-38) Our recent study highlights a novel area of influence for gut microbes and SCFAs—blood…”
BackgroundObesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 370
Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
Liu, R., Zhang, C., Shi, Y., Zhang, F., Li, L., Wang, X., Ling, Y., Fu, H., Dong, W., Shen, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00324 · Cited by 367
Whole Fruits and Fruit Fiber Emerging Health Effects
Dreher, M. (2018) · Nutrients · doi:10.3390/nu10121833 · Cited by 370
“barrier and activating the vagus nerve and hypothalamus to affect appetite and energy intake [127].”
BackgroundButyrate in Energy Metabolism: There Is Still More to Learn
Zhang, L., Liu, C., Jiang, Q., & Yin, Y. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.12.003 · Cited by 364
Microbiota conservation and BMI signatures in adult monozygotic twins
Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., de Vos, W. M., & Zoetendal, E. G. (2013) · The ISME Journal · doi:10.1038/ismej.2012.146 · Cited by 367
“…et al., 2011), aberrant in composition and stability in patients suffering from GI disorders such as Crohn’s disease (Seksik et al., 2003), and associated to host energy homeostasis (Backhed et al., 2004; Ley et al., 2006; Turnbaugh et al., 2006; Backhed et al., 2007; Samuel et al., 2008).”
BackgroundMetabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
Endurance exercise and gut microbiota: A review
Mach, N., & Fuster-Botella, D. (2017) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2016.05.001 · Cited by 361
“Propionate and acetate are carried in the bloodstream to a variety of different organs where they are used as substrates for energy metabolism, particularly by the hepatocyte cells, which use propionate for gluconeogenesis.(11) The gut microbiota also plays a fundamental role in the induction and function of the host…”
BackgroundTremellen, K., & Pearce, K. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.016 · Cited by 359
“While the majority of butyrate is used as an energy source for colonic epithelial cells, acetate and propionate are primarily absorbed by the gut and delivered to the liver where they are used for de novo lipidogenesis [99].”
BackgroundGut microbiota: a new path to treat obesity
on behalf of the Obesity Programs of nutrition, E., Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., & Colao, A. (2019) · International Journal of Obesity Supplements · doi:10.1038/s41367-019-0011-7 · Cited by 354
Bacterial Neuroactive Compounds Produced by Psychobiotics
Wall, R., Cryan, J. F., Ross, R. P., Fitzgerald, G. F., Dinan, T. G., & Stanton, C. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_10 · Cited by 353
Portune, K. J., Beaumont, M., Davila, A.-M., Tomé, D., Blachier, F., & Sanz, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.08.011 · Cited by 356
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
Kootte, R. S., Vrieze, A., Holleman, F., Dallinga‐Thie, G. M., Zoetendal, E. G., de Vos, W. M., Groen, A. K., Hoekstra, J. B. L., Stroes, E. S., & Nieuwdorp, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01483.x · Cited by 351
“An enteroendocrinological pathway is proposed in which SCFAs stimulate the secretion of peptide YY (PYY), a hormone related to obesity [35,36].”
BackgroundGut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
The gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 350
“Samuel et al. have demonstrated that G-protein coupled receptor 41 (GPR41) knockout mice colonised with a specific fermentative microbial community resist fat mass gain compared to their wild-type littermates (Samuel et al., 2008).”
BackgroundSmith, B. J., Miller, R. A., Ericsson, A. C., Harrison, D. C., Strong, R., & Schmidt, T. M. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1494-7 · Cited by 349
“Likewise, both butyrate and propionate activate FFAR3—which can result in increased secretion of PYY and GLP-1 [43, 44] with implications for glucose homeostasis [45]—and inhibit histone deacetylases [46], with downstream effects on both inflammation [47] and carcinogenesis [48].”
BackgroundThe effect of heritability and host genetics on the gut microbiota and metabolic syndrome
Lim, M. Y., You, H. J., Yoon, H. S., Kwon, B., Lee, J. Y., Lee, S., Song, Y.-M., Lee, K., Sung, J., & Ko, G. (2017) · Gut · doi:10.1136/gutjnl-2015-311326 · Cited by 345
The environment within: how gut microbiota may influence metabolism and body composition
Vrieze, A., Holleman, F., Zoetendal, E. G., de Vos, W. M., Hoekstra, J. B. L., & Nieuwdorp, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1662-7 · Cited by 343
“Activation of GPR41 enhances production of peptide YY (PYY), an enteroendocrine cell hormone that normally inhibits gut motility, increases intestinal transit rate and reduces extraction of energy (SCFAs) from the diet, thus affecting peripheral glucose utilisation [26].”
Puddu, A., Sanguineti, R., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/162021 · Cited by 342
Soluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota
Guan, Z.-W., Yu, E.-Z., & Feng, Q. (2021) · Molecules · doi:10.3390/molecules26226802 · Cited by 336
Haenen, D., Zhang, J., Souza da Silva, C., Bosch, G., van der Meer, I. M., van Arkel, J., van den Borne, J. J. G. C., Pérez Gutiérrez, O., Smidt, H., Kemp, B., et al. (2013) · The Journal of Nutrition · doi:10.3945/jn.112.169672 · Cited by 341
Zaibi, M. S., Stocker, C. J., O'Dowd, J., Davies, A., Bellahcene, M., Cawthorne, M. A., Brown, A. J. H., Smith, D. M., & Arch, J. R. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.027 · Cited by 340
“The leanness of the knockout animals was linked to a lower plasma concentration of peptide YY, increased intestinal transit rate and reduced absorption of SCFA [17].”
BackgroundUnderstanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Xu, J., Chen, H., & Li, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21431 · Cited by 340
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Tang, C., Ahmed, K., Gille, A., Lu, S., Gröne, H.-J., Tunaru, S., & Offermanns, S. (2015) · Nature Medicine · doi:10.1038/nm.3779 · Cited by 334
Egerod, K. L., Engelstoft, M. S., Grunddal, K. V., Nøhr, M. K., Secher, A., Sakata, I., Pedersen, J., Windeløv, J. A., Füchtbauer, E.-M., Olsen, J., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1595 · Cited by 334
“A series of reports on transgenic reporter mice expressing variants of GFP under the control of promoters for different gut peptide precursors have been published over the last couple of years without mention of coexpression of nonexpected peptide hormones (23, 28, 36, 37).”
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders
Yoo, J., & Kim, S. (2016) · Nutrients · doi:10.3390/nu8030173 · Cited by 328
“Notably, the effects were not observed in FFAR3-deficient mice.”
InfluentialPalmnäs, M. S. A., Cowan, T. E., Bomhof, M. R., Su, J., Reimer, R. A., Vogel, H. J., Hittel, D. S., & Shearer, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109841 · Cited by 325
“Employing the intestinal G6P knockout mouse (IG6pc-/-), work by De Vadder and colleagues [27] shows that the conversion of propionate via intestinal gluconeogenesis results in the release of glucose in to the portal circulation resulting in metabolic benefits to the host including the activation of Gcoupled free fatty…”
BackgroundHow gut microbes talk to organs: The role of endocrine and nervous routes
Cani, P. D., & Knauf, C. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.011 · Cited by 321
Microbiome therapeutics — Advances and challenges
Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317
Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124332 · Cited by 316
Taste receptors of the gut: emerging roles in health and disease
Depoortere, I. (2014) · Gut · doi:10.1136/gutjnl-2013-305112 · Cited by 315
Kleerebezem, M., & Vaughan, E. E. (2009) · Annual Review of Microbiology · doi:10.1146/annurev.micro.091208.073341 · Cited by 314
“Nutrient acquisition and energy regulation are influenced by an individual’s unique gut microbiota (5, 7, 62, 94, 113).”
BackgroundGut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
The Gut Microbiome Influences Host Endocrine Functions
Rastelli, M., Cani, P. D., & Knauf, C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00280 · Cited by 307
Gut Microbiota-Dependent Modulation of Energy Metabolism
Heiss, C. N., & Olofsson, L. E. (2018) · Journal of Innate Immunity · doi:10.1159/000481519 · Cited by 310
Diamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308
“Gpr41 deficiency was associated with decreased expression of PYY, increased intestinal transit rate, reduced harvest of energy from the diet and decreased hepatic lipogenesis (45).”
BackgroundEffects of the gut microbiota on obesity and glucose homeostasis
Greiner, T., & Bäckhed, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.01.002 · Cited by 304
Bjursell, M., Admyre, T., Göransson, M., Marley, A. E., Smith, D. M., Oscarsson, J., & Bohlooly-Y, M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00229.2010 · Cited by 302
“Interestingly, Ffar3-deficient mice show higher fecal energy, which is explained by increased gastric transit rate (17).”
BackgroundRemely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H., & Haslberger, A. G. (2014) · Gene · doi:10.1016/j.gene.2013.11.081 · Cited by 299
“Inhibition of Gpr41 activation may result in decreased extraction of energy from the diet and leaner individuals (Samuel et al., 2008).”
BackgroundRole of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
Khan, M. J., Gerasimidis, K., Edwards, C. A., & Shaikh, M. G. (2016) · Journal of Obesity · doi:10.1155/2016/7353642 · Cited by 295
“Samuel et al. (2008) demonstrated that GF mice deficient in GPR41 genes remain lean compared with their wild type counterparts, although their body composition was not different [84].”
BackgroundGreen, M., Arora, K., & Prakash, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082890 · Cited by 293
Mechanisms of Gene Regulation by Fatty Acids
Georgiadi, A., & Kersten, S. (2012) · Advances in Nutrition · doi:10.3945/an.111.001602 · Cited by 294
Yang, J., Fernández-Galilea, M., Martínez-Fernández, L., González-Muniesa, P., Pérez-Chávez, A., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Nutrients · doi:10.3390/nu11040872 · Cited by 292
“The gut microbiota also produces microbial metabolites such as short-chain fatty acids (SCFAs) which play a critical role in regulating host energy harvest [55].”
BackgroundVallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis
Zhang, Y.-G., Wu, S., Yi, J., Xia, Y., Jin, D., Zhou, J., & Sun, J. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.12.014 · Cited by 287
Gut microbial metabolites in depression: understanding the biochemical mechanisms
Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019) · Microbial Cell · doi:10.15698/mic2019.10.693 · Cited by 284
Murphy, R., Tsai, P., Jüllig, M., Liu, A., Plank, L., & Booth, M. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2399-2 · Cited by 285
“propionate (the metabolism of which was increased after RYGB) are known to influence host appetite [31], energy extraction and absorption from the diet [32].”
BackgroundThe Intestinal Microbiota in Metabolic Disease
Woting, A., & Blaut, M. (2016) · Nutrients · doi:10.3390/nu8040202 · Cited by 284
Zhang, J., Sun, Z., Jiang, S., Bai, X., Ma, C., Peng, Q., Chen, K., Chang, H., Fang, T., & Zhang, H. (2019) · mSystems · doi:10.1128/msystems.00017-19 · Cited by 282
“SCFAs are present on enteroendocrine cells, and propionate can directly activate the release of PYY and GLP-1 from L-cells both in vitro and in vivo in humans (38, 41, 42).”
BackgroundGut microbiota in obesity and metabolic disorders
Sanz, Y., Santacruz, A., & Gauffin, P. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110001813 · Cited by 281
“leptin and peptide tyrosine–tyrosine) involved in appetite and energy metabolism((27)).”
Microbiota, Disease, and Back to Health: A Metastable Journey
Blumberg, R., & Powrie, F. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004184 · Cited by 281
“Colonization of germ-free mice with fermenting bacteria such as Bacteroides thetaiotaomicron together with organisms that promote the fermentation process such asMethanobacterium smithii restored weight increase and obesity that was dependent on the SCFA receptor, GPCR41 (68).”
BackgroundTseng, C.-H., & Wu, C.-Y. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.07.009 · Cited by 280
Liou, A. P., Lu, X., Sei, Y., Zhao, X., Pechhold, S., Carrero, R. J., Raybould, H. E., & Wank, S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.012 · Cited by 280
Complexity and health functionality of plant cell wall fibers from fruits and vegetables
Padayachee, A., Day, L., Howell, K., & Gidley, M. J. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.850652 · Cited by 279
“…of the Firmicutes and include primarily acetate and propionate, with lesser amounts of butyrate, and even lower amounts of isobutryate, 2- methylpropionate, valerate, isovalerate and hexanoate (Scheppach, 1994;Wong et al., 2006; Samuel et al., 2008; Chassard et al., 2012; Nicholson et al., 2012).”
BackgroundEvaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation
Crawford, P. A., Crowley, J. R., Sambandam, N., Muegge, B. D., Costello, E. K., Hamady, M., Knight, R., & Gordon, J. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902366106 · Cited by 278
“Obesity caused by a null allele in the leptin gene (ob/ob), or by consumption of a high-fat, high-sugar ‘‘Western’’ diet, is associated with a shift in microbial ecology in the distal gut and an increase in the proportional representation of genes in the gut microbiome involved in processing dietary carbohydrates into…”
BackgroundSelf-citationSalazar, N., Dewulf, E. M., Neyrinck, A. M., Bindels, L. B., Cani, P. D., Mahillon, J., de Vos, W. M., Thissen, J.-P., Gueimonde, M., de los Reyes-Gavilán, C. G., et al. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.06.001 · Cited by 278
“Acetate and propionate are also ligands for GPR41 receptor, the activation of which increases adiposity in mice [30].”
Geurts, L., Neyrinck, A. M., Delzenne, N. M., Knauf, C., & Cani, P. D. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0065 · Cited by 277
“The release of those bacterial metabolites allow them to act as regulators of adiposity via G-proteincoupled receptors 41 and 43 (GPR41 and GPR43) and/ or peroxisome proliferator-activated receptor-γ (PPAR γ)-dependent mechanisms (Dewulf et al., 2011; Samuel et al., 2008).”
BackgroundHocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
“Alterations in gut microbiota in obesity can result in altered fatty acid metabolism and composition in adipose tissue and liver in mice (203–205) and may also modulate gut-derived peptide secretion including peptide YY and glucagon-like peptide 1 (GLP-1) secretion, impacting on gut transit time, energy harvest, and s…”
BackgroundJiao, N., Baker, S. S., Nugent, C. A., Tsompana, M., Cai, L., Wang, Y., Buck, M. J., Genco, R. J., Baker, R. D., Zhu, R., et al. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00114.2017 · Cited by 275
Ikeda, T., Nishida, A., Yamano, M., & Kimura, I. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108273 · Cited by 271
G protein-coupled receptors for energy metabolites as new therapeutic targets
Blad, C. C., Tang, C., & Offermanns, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3777 · Cited by 273
Wang, Y., Dilidaxi, D., Wu, Y., Sailike, J., Sun, X., & Nabi, X.-H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109914 · Cited by 270
Miyamoto, J., Mizukure, T., Park, S.-B., Kishino, S., Kimura, I., Hirano, K., Bergamo, P., Rossi, M., Suzuki, T., Arita, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610733 · Cited by 272
“GPR41 is also reported to be involved in energy regulation in response to SCFAs produced by gut microbiota (62).”
BackgroundSerotonin release and uptake in the gastrointestinal tract
Bertrand, P. P., & Bertrand, R. L. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.08.002 · Cited by 270
“, 2008) and CCK cells (Samuel et al., 2008).”
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
Ulven, T. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00111 · Cited by 271
Murphy, E. F., Cotter, P. D., Hogan, A., O'Sullivan, O., Joyce, A., Fouhy, F., Clarke, S. F., Marques, T. M., O'Toole, P. W., Stanton, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-300705 · Cited by 272
Postprandial remodeling of the gut microbiota in Burmese pythons
Costello, E. K., Gordon, J. I., Secor, S. M., & Knight, R. (2010) · The ISME Journal · doi:10.1038/ismej.2010.71 · Cited by 269
“E-mail: rob.knight@colorado.edu The ISME Journal (2010) 4, 1375–1385 & 2010 International Society for Microbial Ecology All rights reserved 1751-7362/10 www.nature.com/ismej intermittently available (Backhed et al., 2004; Ley et al., 2005; Turnbaugh et al., 2006, 2009a; Samuel et al., 2008).”
Self-citationComplex Pharmacology of Free Fatty Acid Receptors
Milligan, G., Shimpukade, B., Ulven, T., & Hudson, B. D. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00056 · Cited by 267
The nutrition‐gut microbiome‐physiology axis and allergic diseases
McKenzie, C., Tan, J., Macia, L., & Mackay, C. R. (2017) · Immunological Reviews · doi:10.1111/imr.12556 · Cited by 270
Pathways in Microbe-Induced Obesity
Cox, L. M., & Blaser, M. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.004 · Cited by 266
Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Holle, A. V., Muccioli, G. G., Deldicque, L., Bindels, L. B., Pachikian, B. D., Sohet, F. M., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.05.009 · Cited by 269
“Other molecular targets have been proposed recently, among which G protein-coupled receptors (GPR) 41 and 43 which are activated by short chain fatty acids (SCFA) generated by bacterial gut fermentation of nondigestible carbohydrates [11–13].”
BackgroundThe Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Bolognini, D., Tobin, A. B., Milligan, G., & Hodge, D. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.102301 · Cited by 267
“, 2013), and the same amount of adipose tissue as wild type (Samuel et al., 2008).”
BackgroundNøhr, M. K., Egerod, K. L., Christiansen, S. H., Gille, A., Offermanns, S., Schwartz, T. W., & Møller, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.040 · Cited by 266
“FFAR3 expression is seen in enteroendocrine cells (Samuel et al., 2008; Tazoe et al., 2009), enteric nervous system (Nøhr et al.”
BackgroundThe host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept
Van den Abbeele, P., Van de Wiele, T., Verstraete, W., & Possemiers, S. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00270.x · Cited by 264
Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention
Zeng, H. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i2.41 · Cited by 266
The gut microbiome: the role of a virtual organ in the endocrinology of the host
Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0131 · Cited by 264
“Mice that have had their FFAR3 knocked out (Samuel et al. 2008) show an associated reduction in the expression of PYY, increased intestinal transit rate and reduced harvest of energy (SCFAs) from the diet.”
BackgroundHou, H., Chen, D., Zhang, K., Zhang, W., Liu, T., Wang, S., Dai, X., Wang, B., Zhong, W., & Cao, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.11.027 · Cited by 263
Han, Y., Wang, B., Gao, H., He, C., Hua, R., Liang, C., Zhang, S., Wang, Y., Xin, S., & Xu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s384949 · Cited by 265
“Moreover, there are also TLR or other receptors on EECs, which can recognize bacterial products in the intestinal lumen, such as LPS and SCFA, thus effect on vagal afferents.(48)”
BackgroundIs butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
Brahe, L. K., Astrup, A., & Larsen, L. H. (2013) · Obesity Reviews · doi:10.1111/obr.12068 · Cited by 264
“So far, studies in ffar2 and ffar3 knockout mice have yielded conflicting results; some have suggested that the activity of these receptors is beneficial in relation to prevention of obesity and related metabolic disturbances (26,41,43), while others have suggested that inhibition of their activity may prevent metabol…”
BackgroundDaily eating patterns and their impact on health and disease
Zarrinpar, A., Chaix, A., & Panda, S. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.11.007 · Cited by 263
“In addition, microbiota-produced SCFAs that activate GPR41 can affect host energy homeostasis by stimulating adipocytes into making leptin [76], and inducing glucagon-like peptide 1 (GLP-1) secretion by intestinal EECs [74].”
Role of the Gut Microbiome in Obesity and Diabetes Mellitus
Barlow, G. M., Yu, A., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 262
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases
Coppola, S., Avagliano, C., Calignano, A., & Berni Canani, R. (2021) · Molecules · doi:10.3390/molecules26030682 · Cited by 261
Metadata
- Authors
- Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., & Gordon, J. I.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas Southwestern Medical Center (US)
- Japan Science and Technology Agency (JP)
- *Center for Genome Sciences and
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-28
- Volume
- 105
- Issue
- 43
- Pages
- 16767-16772
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2569967
- OpenAlex
- W2142336938
- Cited by
- 1,564
- References
- 23
- Citations by year
- 2026: 51 · 2025: 83 · 2024: 71 · 2023: 93 · 2022: 110 · 2021: 137 · 2020: 127 · 2019: 110 · 2018: 107 · 2017: 104 · 2016: 110 · 2015: 87 · 2014: 88 · 2013: 80 · 2012: 70
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 70977, R01DK070977, P30DK056341, R01DK030292)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- GPR41, gut microbiota, adiposity, short-chain fatty acids, energy balance, Bacteroides thetaiotaomicron, Methanobrevibacter smithii, peptide YY, enteroendocrine cells, intestinal transit, gnotobiotic mice, germ-free mice, polysaccharide fermentation, host-microbe interactions
- MeSH terms
- Animals, Bacteroides, Energy Metabolism, Germ-Free Life, Humans, Symbiosis, Mice, Knockout, Peptide YY, Methanobrevibacter, Gastrointestinal Tract, Receptors, G-Protein-Coupled, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.